Galactosamine is a hexosamine derived from galactose with the molecular formula C6H13NO5. A few amino sugars, including galactosamine, have been shown to kill tumors in the laboratory. It is unlikely to be used in cancer therapy, however. D-galactosamine is a hepatotoxic, or liver-damaging, agent. Researchers studying animal models of liver failure sometimes use D-galactosamine to induce liver damage. Galactosamine is also helpful for researchers studying agents that might protect the liver from damage.

1-Ethyl-3-[3-(dimethylamino)propyl]carbodiimide (EDC) is a water-soluble carbodiimide. EDC is commonly used for the peptide synthesis, protein crosslinking to nucleic acids, preparation of immunoconjugates. EDC is also used in combination with N-hydroxysuccinimide (NHS) for the immobilisation of large biomolecules.

Galactosamine is a hexosamine derived from galactose with the molecular formula C6H13NO5. A few amino sugars, including galactosamine, have been shown to kill tumors in the laboratory. It is unlikely to be used in cancer therapy, however. D-galactosamine is a hepatotoxic, or liver-damaging, agent. Researchers studying animal models of liver failure sometimes use D-galactosamine to induce liver damage. Galactosamine is also helpful for researchers studying agents that might protect the liver from damage.

1-Ethyl-3-[3-(dimethylamino)propyl]carbodiimide (EDC) is a water-soluble carbodiimide. EDC is commonly used for the peptide synthesis, protein crosslinking to nucleic acids, preparation of immunoconjugates. EDC is also used in combination with N-hydroxysuccinimide (NHS) for the immobilisation of large biomolecules.